PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 201 filers reported holding PUMA BIOTECHNOLOGY INC in Q2 2015. The put-call ratio across all filers is 0.90 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $50,000 | -23.1% | 7,106 | 0.0% | 0.00% | – |
Q2 2021 | $65,000 | -5.8% | 7,106 | 0.0% | 0.00% | – |
Q1 2021 | $69,000 | -5.5% | 7,106 | 0.0% | 0.00% | – |
Q4 2020 | $73,000 | +1.4% | 7,106 | 0.0% | 0.00% | – |
Q3 2020 | $72,000 | -2.7% | 7,106 | 0.0% | 0.00% | – |
Q2 2020 | $74,000 | +23.3% | 7,106 | 0.0% | 0.00% | – |
Q1 2020 | $60,000 | +13.2% | 7,106 | +16.8% | 0.00% | – |
Q4 2019 | $53,000 | -19.7% | 6,086 | 0.0% | 0.00% | – |
Q3 2019 | $66,000 | -14.3% | 6,086 | 0.0% | 0.00% | – |
Q2 2019 | $77,000 | -67.4% | 6,086 | 0.0% | 0.00% | -100.0% |
Q1 2019 | $236,000 | +90.3% | 6,086 | 0.0% | 0.00% | +100.0% |
Q4 2018 | $124,000 | -55.6% | 6,086 | 0.0% | 0.00% | -50.0% |
Q3 2018 | $279,000 | -22.5% | 6,086 | 0.0% | 0.00% | 0.0% |
Q2 2018 | $360,000 | -13.0% | 6,086 | 0.0% | 0.00% | -33.3% |
Q1 2018 | $414,000 | -35.3% | 6,086 | -5.9% | 0.00% | -25.0% |
Q4 2017 | $640,000 | -17.4% | 6,471 | 0.0% | 0.00% | -33.3% |
Q3 2017 | $775,000 | +36.9% | 6,471 | 0.0% | 0.01% | +50.0% |
Q2 2017 | $566,000 | +134.9% | 6,471 | 0.0% | 0.00% | +100.0% |
Q1 2017 | $241,000 | +21.1% | 6,471 | 0.0% | 0.00% | 0.0% |
Q4 2016 | $199,000 | -54.1% | 6,471 | 0.0% | 0.00% | -50.0% |
Q3 2016 | $434,000 | +124.9% | 6,471 | 0.0% | 0.00% | +100.0% |
Q2 2016 | $193,000 | -9.8% | 6,471 | -11.0% | 0.00% | 0.0% |
Q1 2016 | $214,000 | -62.5% | 7,274 | -0.0% | 0.00% | -60.0% |
Q4 2015 | $570,000 | +4.0% | 7,275 | +0.1% | 0.01% | 0.0% |
Q3 2015 | $548,000 | -35.5% | 7,268 | -0.1% | 0.01% | -28.6% |
Q2 2015 | $850,000 | -44.4% | 7,277 | +12.5% | 0.01% | -46.2% |
Q1 2015 | $1,528,000 | +24.7% | 6,471 | 0.0% | 0.01% | +30.0% |
Q4 2014 | $1,225,000 | -20.7% | 6,471 | 0.0% | 0.01% | -23.1% |
Q3 2014 | $1,544,000 | +119.6% | 6,471 | -39.2% | 0.01% | +116.7% |
Q2 2014 | $703,000 | – | 10,651 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 1,300,000 | $13,338,000 | 2.17% |
Camber Capital Management LP | 2,555,000 | $26,214,000 | 0.92% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,959,741 | $40,627,000 | 0.80% |
Palo Alto Investors LP | 1,373,897 | $14,096,000 | 0.74% |
Sofinnova Investments, Inc. | 629,650 | $6,460,000 | 0.38% |
RICE HALL JAMES & ASSOCIATES, LLC | 604,937 | $6,207,000 | 0.22% |
J. Goldman & Co LP | 238,617 | $2,448,000 | 0.12% |
GLOBEFLEX CAPITAL L P | 55,027 | $565,000 | 0.12% |
FRED ALGER MANAGEMENT, LLC | 3,416,003 | $35,048,000 | 0.09% |
JUPITER ASSET MANAGEMENT LTD | 728,440 | $7,474,000 | 0.08% |